ENTOINNOV
Seed Round in 2024
Entoinnov is a biotechnology company that specializes in converting agricultural waste into high-value, insect-based ingredients. It develops a proprietary bioprocess that transforms organic waste into nutritious, protein-rich ingredients suitable for both human and animal consumption. This process not only creates a sustainable source of superfood ingredients but also helps minimize environmental impact by reducing organic waste.
C & Dac
Venture Round in 2024
C & Dac is a food company that research and develops new food products and meet sustainable food.
Odimma is a biotech company specializing in precision medicine aimed at developing personalized cancer immunotherapy solutions. The company has created an innovative immunotherapy drug that harnesses a unique platform, integrating three specific immune components designed to work together with the patient's immune system. When administered, this approach aims to induce and enhance immune responses, providing patients with the potential to eliminate tumors while minimizing adverse side effects. Through its focus on personalized treatment strategies, Odimma seeks to improve outcomes for cancer patients by tailoring therapies to individual needs.
Miraxess
Venture Round in 2023
Miraxess is a French technology company that develops a plug‑in device called the Mirabook, which extends a smartphone into a full‑featured laptop. The device connects to the phone, providing a larger display, keyboard, and mouse input, thereby enabling users to perform work and entertainment tasks with greater productivity and comfort. By converting mobile phones into portable computing platforms, Miraxess offers a mobile convergence solution that addresses the growing reliance on smartphones for daily digital needs.
Spartha Medical
Seed Round in 2021
Spartha Medical is a medical technology company focused on developing innovative coatings designed to enhance the safety of medical devices and consumer products. The company utilizes eco-friendly and biocompatible coatings made from natural biopolymers, which possess antibacterial, antiviral, and anti-inflammatory properties. Their patented technology allows for precise control over the assembly of two distinct polyelectrolytes, enabling the creation of versatile and multifunctional surface coatings tailored to specific applications. By providing effective solutions that protect users from microbial and inflammatory risks, Spartha Medical aims to improve healthcare outcomes and promote safer use of medical devices across various healthcare settings.
Direct Market
Venture Round in 2021
Direct Market operates an online foodtech platform designed to connect producers and traders and to support sustainable food systems. The platform enables ordering, logistics, invoicing, payment, and transparency across the supply chain, helping participants manage transactions and partnerships more efficiently. It also provides marketplace creation, platform-as-a-service for existing brands, and on-premise marketplace installation, along with software development for supply chain management. Through these capabilities, Direct Market helps businesses and organizations create or integrate local food marketplaces, improve transparency and customer connections, and collect data to support a more resilient and traceable food system.
Kwit develops a mobile application that supports smoking cessation by applying evidence-based methods and cognitive-behavioral therapy principles. The app provides daily guidance and encouragement focused on positivity and kindness to help users quit smoking and pursue a healthier, smoke-free life.
Holodia
Angel Round in 2018
Holodia is a developer of a virtual reality (VR) fitness platform known as HOLOFIT, which aims to transform indoor cardio workouts through immersive experiences. The platform offers a variety of training modalities, including biking, rowing, and running, utilizing proprietary VR technology and unique content created by an in-house design team. HOLOFIT focuses on enhancing user engagement by gamifying fitness through effort-based challenges, adaptive training programs, and AI-driven virtual coaching. Users can participate in exciting virtual environments and compete in both location-based and online competitions within the HOLOFIT community, making workouts more enjoyable and motivating. By merging gaming elements with fitness, Holodia provides a novel approach to cardio training that caters to a diverse audience.
Fizimed
Seed Round in 2018
Fizimed SAS is a French company based in Strasbourg that specializes in developing medical devices aimed at addressing urinary incontinence in women. The company's flagship product, EMY, is a perineal probe designed to facilitate pelvic floor muscle reeducation. EMY connects to a mobile application, allowing users to engage in customized, interactive exercises that strengthen their pelvic floor while tracking their progress in real time. The device incorporates gamified elements to motivate users, offering various activities that turn exercises into enjoyable challenges. Founded in 2017, Fizimed is committed to balancing the safety and quality of medical devices with user-friendly technology, while actively working to destigmatize urinary incontinence—a common issue affecting one in ten women. Through social media initiatives, Fizimed fosters a community that encourages open discussions around this topic, aiming to empower women to take control of their health and well-being.
Qwesta is a company based in Obernai, France, that specializes in developing a platform designed to diagnose business performance. Established in 2015, Qwesta offers web-based enhanced consulting solutions aimed at business experts, such as consultants and trainers, enabling them to enhance the value of their services. Additionally, the company provides automated consulting tools for managers to support their decision-making processes. Central to Qwesta's offerings is its innovative technology that allows users to create various forms for collecting intelligent feedback, known as Qwestannaires. This streamlined approach facilitates both the assessment and improvement of business practices.
Prix-de-gros.com
Seed Round in 2017
Prix-de-gros.com is the market place to develop unique technological bricks perfectly meeting the needs of sellers but also buyers, with a ceaseless quest the best products at the best price. In constant progression since its launch, with a clear acceleration this year, the time has come to start higher speed to accelerate its development.
Myfood specializes in designing automated connected greenhouses that empower individuals to produce their own food sustainably. The company focuses on creating user-friendly solutions that enable families of up to four to grow fresh produce year-round in their own gardens. Utilizing advanced permaculture techniques, Myfood's greenhouses enhance soil health and incorporate aquaponics, which fosters a symbiotic relationship between fish and plants. The innovative design features vertical plantation towers and self-fertile garden beds enriched with compost, organic materials, and biochar to optimize production. To reduce maintenance efforts, Myfood integrates open-source hardware that automates various tasks, providing users with a modern and efficient personal gardening system.
WhiteQuest
Seed Round in 2016
WhiteQuest is a French company specializing in the development of innovative training solutions for industrial sectors. It focuses on creating digital tools that enhance the training process for employees and customers, particularly in the Pharmaceutical and Medical industries. WhiteQuest's offerings include digital sales tools, interactive 3D user manuals, mobile diagnostic and troubleshooting applications, and virtual simulations. These custom-made solutions aim to streamline training and improve the maintenance of industrial equipment, ultimately enabling companies to optimize their operations and enhance customer service.
ID Nest Medical
Seed Round in 2016
ID Nest Medical SAS is a medical device company based in Strasbourg, France, specializing in the development of innovative endoprosthetic solutions for vascular conditions. Incorporated in 2014, the company focuses on restoring the functionality of vascular bifurcations, particularly in patients with aortic arch aneurysms. ID Nest Medical has introduced the ID arterial system, featuring fenestrated endoprostheses that are delivered through the iliac artery, and the ID CovBranch endoprostheses, which ensure a compliant connection that accommodates anatomical movements. Additionally, the company offers the ID Venous System, which includes ID Cav and ID Branch, designed to support the iliocava bifurcation and prevent stent migration while addressing compressed iliac veins. The company's products aim to simplify procedures and enhance the long-term functionality of vascular treatments, addressing challenges faced by medical professionals in the field.
Urbiotop
Seed Round in 2016
Urbiotop is a biotech company that manufactures and sells LOMBRI-COMPOST and offers local RECYCLING solutions for household BIO-WASTE
Collection at Public or Private Voluntary Contribution Points.
Bionext
Seed Round in 2015
Bionext S.A. is a biotechnology company based in Strasbourg, France, specializing in bioinformatics and the development of advanced software tools aimed at enhancing drug discovery and development processes. Founded in 2009, Bionext focuses on creating a three-dimensional molecular visualization software that integrates big data, cloud computing, and OMICS data. This platform enables pharmaceutical and biotechnology companies to visualize and simulate drug interactions within human cells, thereby improving the understanding and prediction of drug efficacy and side effects. Additionally, Bionext offers a virtual screening platform that models cellular environments to facilitate high-throughput screening and early assessments of new compounds in pharmaceuticals, cosmetics, and agri-food sectors. The company is dedicated to addressing critical challenges in drug development, including drug profile assessment and repurposing strategies.
Rhenovia Pharma
Series B in 2014
Rhenovia Pharma SAS is a French biotechnology company founded in 2007 by an international team that brings together managers from large pharmaceutical companies and world experts in neuroscience and nervous system modeling. The company is the world leader in the application of biosimulation in the prevention and treatment of neurological, neurodegenerative and psychiatric disorders and diseases. Based in Mulhouse (France) and Cambridge (Massachusetts), Rhenovia has around twenty members of staff in France, Switzerland, Germany and the US.
Xilopix SAS
Venture Round in 2013
Xilopix SAS provides a SaaS based digital asset management softwar,e Xilopix, developers of the first fully Multimedia Content Search and Navigation Engine designed for the touch screen revolution. Xilopix's Multimedia Search Engine technology enables users to find Images and any Multimedia objects quicker and with unrivaled precision
Infinite Vision Optics
Seed Round in 2013
Infinite Vision Optics is a medical technology company focused on developing innovative solutions for cataract patients through its PreciSight® intraocular lens system. This system features adjustable intraocular lenses that can be customized for each patient, allowing for refractive adjustments throughout their lives. The technology addresses presbyopia and astigmatism corrections without the need for complete lens explantation, significantly reducing the risks associated with traditional lens replacement procedures. By utilizing a proprietary docking station, surgeons can achieve optimal refractive outcomes for their patients, providing lasting solutions to changes in vision that may occur over time.
eNovalys
Seed Round in 2010
eNovalys SAS, founded in 2009 and located in Illkirch-Graffenstaden, France, specializes in web-based software that provides essential chemical information. The company offers a range of products designed to enhance the efficiency of chemists. Its flagship product, ePro, is an electronic laboratory notebook that includes a chemical management system while ensuring intellectual property compliance. eNovalys also provides eProis, which facilitates information exchange among lab members and partners, and eShare, a platform for publishing chemical research. Additionally, eLight combines an electronic lab notebook with the eSniff search engine, which allows users to access a comprehensive database of both successful and failed chemical reactions. This patented search engine helps chemists avoid repeating past mistakes by aggregating extensive data on chemical experiments. Through these offerings, eNovalys aims to streamline the research and development process in the field of chemistry.
CellProthera
Seed Round in 2009
CellProthera is a pioneering medical biotechnology company focused on developing innovative cell therapies for heart muscle repair. Its flagship product involves the use of autologous CD34+ stem cells to regenerate damaged heart tissue following acute myocardial infarction (heart attack), demonstrating excellent safety profiles and significant clinical benefits in early trials. Experts consider this approach one of the most promising strategies to treat AMI and prevent secondary congestive heart failure.
Rhenovia Pharma
Angel Round in 2009
Rhenovia Pharma SAS is a French biotechnology company founded in 2007 by an international team that brings together managers from large pharmaceutical companies and world experts in neuroscience and nervous system modeling. The company is the world leader in the application of biosimulation in the prevention and treatment of neurological, neurodegenerative and psychiatric disorders and diseases. Based in Mulhouse (France) and Cambridge (Massachusetts), Rhenovia has around twenty members of staff in France, Switzerland, Germany and the US.
Pertech Solutions
Venture Round in 2009
Pertech Solutions is a French company that specializes in the design, development, production, and marketing of eye tracking technologies. The company focuses on utilizing eye movement as a key element for interaction between humans and control systems, enhancing both usability and security. Pertech offers innovative solutions across various sectors, including health, industry, automotive, and aeronautics. Their advanced platform enables the analysis of human behavior through eye activity in both real and simulated environments, facilitating improved human-machine interactions and user experience.